Lilly's $2.75B AI Drug Deal + Apple's Strategy Shift

(0:15) Eli Lilly Signs $2.75 Billion Deal for AI-Discovered Drugs From Insilico Medicine (1:25) Apple Repositions AI as a Platform Play Modeled on the App Store (2:33) New Zealand Agtech Startup Halter Raises $220 Million for AI Cow Collars